Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Selim Gürel"'
Autor:
Ahmet Tarık Eminler, Enver Dolar, Kader Irak, Macit Gülten, Murat Keskin, Murat Kıyıcı, Mustafa Ihsan Uslan, Selim Gürel, Selim Giray Nak, Talat Ayyıldız
Publikováno v:
Sakarya Tıp Dergisi, Vol 4, Iss 2, Pp 74-77 (2014)
Amaç: Bu çalışmanın amacı high-grade displazi (HGD) ve invaziv kanser ( “ilerlemiş patoloji (İP)” olarak tanımlanmıştır) ile ilişkili multipl hasta ve adenom karakterlerini değerlendirmektir. Materyal ve Metod: Toplam 6250 işlem
Externí odkaz:
https://doaj.org/article/49e7d843602a42dc8eabcb78982bbf69
Autor:
Anika Wranke, Benjamin Heidrich, Stefanie Ernst, Beatriz Calle Serrano, Florin Alexandru Caruntu, Manuela Gabriela Curescu, Kendal Yalcin, Selim Gürel, Stefan Zeuzem, Andreas Erhardt, Stefan Lüth, George V Papatheodoridis, Birgit Bremer, Judith Stift, Jan Grabowski, Janina Kirschner, Kerstin Port, Markus Cornberg, Christine S Falk, Hans-Peter Dienes, Svenja Hardtke, Michael P Manns, Cihan Yurdaydin, Heiner Wedemeyer, HIDIT-2 Study Group
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101002 (2014)
Hepatitis delta frequently leads to liver cirrhosis and hepatic decompensation. As treatment options are limited, there is a need for biomarkers to determine disease activity and to predict the risk of disease progression. We hypothesized that anti-H
Externí odkaz:
https://doaj.org/article/37e9e3e2e8ec4160824f875cfb67f7bd
Publikováno v:
Volume: 5, Issue: 1 9-14
Turkish Journal of Internal Medicine
Turkish Journal of Internal Medicine
Background Interferon and ribavirin treatments previously used in treating chronic hepatitis C virus (HCV) infection cannot be used effectively in hemodialysis patients due to dose adjustment and drug-related side effects. Direct-acting antivirals (D
Autor:
Michael P. Manns, Fehmi Tabak, Frank Lammert, Markus Cornberg, George N. Dalekos, Kendal Yalcin, Tobias Müller, Svenja Hardtke, Ramazan Idilman, Heiner Wedemeyer, Cihan Yurdaydin, Yilmaz Cakaloglu, Ulus Salih Akarca, M. Wöbse, A. Wranke, Dieter Häussinger, Benjamin Heidrich, Selim Gürel
Publikováno v:
Journal of Viral Hepatitis
Hepatitis delta virus (HDV) infection causes the most severe form of viral hepatitis. PEG-interferon alpha-2a (PEG-IFN alpha-2a) is the only effective treatment but its long-term clinical impact is unclear. the aim of this study was to investigate th
Autor:
Stefan Lüth, Selim Gürel, George V. Papatheodoridis, Birgit Bremer, Olympia E. Anastasiou, Manuela Curescu, Ulus Salih Akarca, Heiner Wedemeyer, Ramazan Idilman, Kendal Yalcin, Florin Alexandru Caruntu, Markus Cornberg, Cihan Yurdaydin, Andreas Erhardt, Stefan Zeuzem, Svenja Hardtke, Monica Radu, Michael P. Manns
Publikováno v:
Liver International
The role of low levels of HDV-RNA during and after interferon therapy of hepatitis D is unknown. We re-analysed HDV RNA in 372 samples collected in the HIDIT-2 trial (Wedemeyer et al, Lancet Infectious Diseases 2019) with the Robogene assay (RA; Jena
Autor:
Heike Bantel, Cihan Yurdaydin, Florin Alexandru Caruntu, Stephanie Liebig, Monica Radu, Olympia E. Anastasiou, Michael P. Manns, Stefan Zeuzem, Svenja Hardtke, Birgit Bremer, Markus Cornberg, Heiner Wedemeyer, Kendal Yalcin, Benjamin Maasoumy, Manuela Curescu, Stefan Lüth, Andreas Erhardt, Ulus Salih Akarca, Selim Gürel, George V. Papatheodoridis
Publikováno v:
Journal of viral hepatitisREFERENCES. 28(2)
HBV-DNA levels are low or even undetectable in the majority HDV-infected patients. The impact of PEG-IFN alpha on HBV-DNA kinetics in HDV-infected patients has not been studied in detail. We analysed data of a prospective treatment trial where 120 HD
Publikováno v:
Journal of Gastroenterology and Hepatology Research. 7:2569-2573
AIMS: In the present study, we aimed to evaluate the impact of sustained virological response (SVR) and some other predictive factors on development of cirrhosis secondary to chronic hepatitis C (CHC). MATERIALS AND METHODS: 100 patients with CHC, wh
Autor:
Georgios Papatheodoridis, F.A. Caruntu, Andreas Erhardt, Kendal Yalcin, K Port, Ramazan Idilman, Monica Radu, Manuela Curescu, Stefan Zeuzem, Heiner Wedemeyer, Cihan Yurdaydin, S Hardtke, Stefan Lüth, M Cornberg, M.P. Manns, Ulus Salih Akarca, Selim Gürel
Publikováno v:
Zeitschrift für Gastroenterologie.
Autor:
Heiko von der Leyen, Kendal Yalcin, Ingmar Mederacke, Markus Cornberg, Ramazan Idilman, Stefan Lüth, Kerstin Port, Hans Peter Dienes, Judith Stift, Ulrike Wittkop, Cihan Yurdaydin, Manuela Curescu, Mustafa Kemal Çelen, Kristina Weber, Onur Keskin, Svenja Hardtke, Selim Gürel, Hidit-Ii study team, Monica Radu, Michael P. Manns, Andreas Erhardt, Heiner Wedemeyer, Benjamin Heidrich, Armin Koch, Ulus Salih Akarca, George V. Papatheodoridis, Florin Alexandru Caruntu, Stefan Zeuzem
Summary Background Hepatitis D is the most severe form of chronic viral hepatitis. Treatment guidelines recommend 1 year of peginterferon alfa, which is effective in 25–30% of patients only. Whether prolonged therapy with peginterferon alfa-2a for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9119c7b5a52a53c15a1bef95f500203a
http://hdl.handle.net/11452/29598
http://hdl.handle.net/11452/29598
Publikováno v:
Journal of Clinical and Experimental Investigations, Vol 7, Iss 2, Pp 203-206 (2016)
Volume: 7, Issue: 2 203-206
Journal of Clinical and Experimental Investigations
Volume: 7, Issue: 2 203-206
Journal of Clinical and Experimental Investigations
Pancreatic pseudocyst is the most common cystic lesion of the pancreas seen following acute and chronic pancreatitis in 2-10% and 10-30%, respectively. Imaging findings vary depending on the age and severity of the attack. Infection, hemorrhage and r